Skip to main content
ImmuneCited

Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids.

D R Robinson
Review Rheumatic diseases clinics of North America 1991 19 citations
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D1862233'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Review
Population
animal model
Intervention
Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids. None
Comparateur
None
Critère de jugement principal
lipid levels
Direction de l'effet
Positive
Risque de biais
Unclear

Abstract

Dietary marine lipids that are enriched in omega-3, or n-3, fatty acids reduce the severity of autoimmune glomerulonephritis in several inbred murine strains. The protective effect of dietary n-3 fatty acids is also seen with a rat model of immune-complex induced vasculopathy, but no protective effects were seen with autoimmune vasculitis in the MRL/lpr mouse or with type II collagen-induced arthritis in rats. Dietary n-3 fatty acids are potential therapeutic agents for the treatment of autoimmune diseases, but careful clinical trials with the purified forms of n-3 fatty acids are needed to determine the usefulness of this intervention.

En bref

Dietary marine lipids that are enriched in omega-3, or n, fatty acids reduce the severity of autoimmune glomerulonephritis in several inbred murine strains and are potential therapeutic agents for the treatment of autoimmune diseases.

Used In Evidence Reviews

Similar Papers